Soleus Capital Management, L.P. - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,598,875
+827.7%
237,500
+853.8%
1.53%
+669.3%
Q2 2023$1,789,314
+40.1%
24,900
+20.3%
0.20%
+50.8%
Q1 2023$1,276,776
-66.9%
20,700
-58.6%
0.13%
-76.1%
Q4 2022$3,856,50050,0000.55%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders